Skip to main content

Cipla, Iceland#39;s Alvotech ink pact to sell biosimilar Adalimumab in emerging markets

Cipla, Iceland#39;s Alvotech ink pact to sell biosimilar Adalimumab in emerging markets As per the partnership, Alvotech will be responsible for development and supply of the product, whereas Cipla will be responsible for registration and commercialisation of the product

from Moneycontrol Business News https://ift.tt/310P6Os
Labels:

Comments

Post a Comment

Popular posts from this blog

German cabinet to hold secret session on Huawei#39;s role in 5G network: Report

Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology for spying, which the company denies. from Moneycontrol Business News http://bit.ly/2TyXzFb
Post a Comment
Read more

Infosys partners Avaloq to strengthen wealth management capabilities via digital platforms

Infosys will be a strategic implementation partner for Avaloq#39;s wealth management suite of solutions to help clients modernize and transform their legacy systems into cutting-edge digital advisory platforms, a statement said. from Moneycontrol Business News https://ift.tt/2THaSpn
Post a Comment
Read more